Publications

Effect of deoxyribonuclease I treatment for dementia in end-stage Alzheimer’s disease: a case report

Journal of Medical Case Reports (2016)

Antimicrobial activity of Mul-1867, a novel antimicrobial compound, against multidrug-resistant Pseudomonas aeruginosa

Annals of Clinical Microbiology and Antimicrobials (2016)

Experimental treatment for dementia in end-stage Alzheimer’s disease: a case report

NEW YORK (May 5, 2016) – Human Microbiology Institute is delighted to announce that its scientific core played a primary role in the groundbreaking study for the treatment of dementia in end-stage Alzheimer’s disease.

Genomic characterization and assessment of the virulence of the novel Paenibacillus sp. VT-400, a potentially pathogenic bacterium

Genomic characterization and assessment of the virulence and antibiotic resistance of the novel species Paenibacillus sp. strain VT-400, a potentially  pathogenic bacterium in the oral cavity of patients with hematological  malignancies

Gut pathogens (2016)

In vitro antimicrobial activity of a novel compound, Mul-1867, against clinically important bacteria.

Annals of Clinical Microbiology and Antimicrobials (2015)

Draft Genome Sequence of Acinetobacter sp. strain VT-511 Isolated from the Stomach of a Patient with Gastric Cancer

Genome announcements (2015)

Complete Genome Sequence of Paenibacillus sp. strain VT-400, Isolated from the Saliva of a Child with Acute Lymphoblastic Leukemia

Genome announcements (2015)

Complete genome sequence of Bacilli bacterium strain VT-13- 104 isolated from the intestine of a patient with duodenal cancer.

Genome announcements (2015)

DNase I Treatment Reduces GVHD in Mice

Biology of Blood and Marrow Transplant (2015)

Mul-1867, A Drug Candidate For Inhalation Therapy Of Pulmonary Exacerbations Caused By Burkholderia Cepacia Complex In Cystic Fibrosis And Copd Patients